A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 40wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 40wt%. Uses: Screen technology, electronics, solar, heat and em shielding, conductive coatings. Group: Doped nanoparticles. |  |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 20wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 20wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 40wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 40wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Dopentacontane | Dopentacontane. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DOPENTACONTANE;ALKANE C52;N-DOPENTACONTANE;DOPENTACONTANE, STANDARD FOR GC. Product Category: Heterocyclic Organic Compound. CAS No. 7719-79-1. Molecular formula: C52H106. Mole weight: 731.4. Product ID: ACM7719791. Alfa Chemistry ISO 9001:2015 Certified. |  |
| DOPE-PEG-Biotin | DOPE-PEG-Biotin is a heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and a biotin. It can be used in targeted drug delivery with the lipid bilayer. Synonyms: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(polyethylene glycol)-Biotin. |  |
| Dopexamine | Dopexamine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DOPEXAMINE;4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol;Dopacard;FPL-60278;FPL-60278AR;4-[2-[[6-(Phenethylamino)hexyl]amino]ethyl]-1,2-benzenediol;1,2-Benzenediol, 4-(2-((6-((2-phenylethyl)amino)hexyl)amino)ethyl)-;86484-91-5 (Di-hyd. Product Category: Heterocyclic Organic Compound. CAS No. 86197-47-9. Molecular formula: C22H32N2O2. Mole weight: 356.507. Product ID: ACM86197479. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dopexamine | Dopexamine is a synthetic dopamine analog and acts as a β2-adrenergic receptor agonist as well as an agonist at peripheral dopamine receptors. It has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Uses: Adrenergic beta-agonists. Synonyms: 1,2-Benzenediol, 4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]-; 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol; FPL 60278; 4-(2-((6-(Phenethylamino)hexyl)amino)ethyl)pyrocatechol. Grade: 95%. CAS No. 86197-47-9. Molecular formula: C22H32N2O2. Mole weight: 356.50. | |
| Dopexamine hydrochloride | Dopexamine hydrochloride is a β2 adrenergic receptor agonist. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FPL60278AR. CAS No. 86484-91-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-U00205. |  |
| Dopexamine hydrochloride | Dopexamine is a synthetic dopamine analog and acts as a β2-adrenergic receptor agonist as well as an agonist at peripheral dopamine receptors. It has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Synonyms: 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol Dihydrochloride; Dopacard; Dopexamine Dihydrochloride; FPL 60278AR. Grade: 95%. CAS No. 86484-91-5. Molecular formula: C22H34Cl2N2O2. Mole weight: 429.43. | |
| Dopexamine Hydrochloride | Dopexamine is a synthetic dopamine analog and acts as a a β2-adrenergic receptor agonistt as well as an agonist at peripheral dopamine receptors. Dopexamine has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Group: Biochemicals. Alternative Names: 4- [2- [ [6- [ (2-Phenylethyl) amino] hexyl] amino] ethyl] -1, 2-benzenediol Dihydrochloride; Dopacard; Dopexamine Dihydrochloride; FPL 60278AR. Grades: Highly Purified. CAS No. 86484-91-5. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| DOPG | DOPG is a phosphatidylglycerol in which the phosphatidyl acyl groups are both oleoyl. It has been used to physically stabilize emulsions and suspensions. It is also used in formulations of pulmonary surfactants, intravenous fat emulsions, and oral solutions. Synonyms: Dioleoyl phosphatidylglycerol; 1,2-Dioctadecenoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; C18:1 phosphatidylglycerol; C18:1 PG; DOPG; 3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-[(9Z)-octadec-9-enoyloxy]propyl (9Z)-octadec-9-enoate. Grade: ≥95% by HPLC. CAS No. 62700-69-0. Molecular formula: C42H79O10P. Mole weight: 775.04. | |
| DOPG:Chol (70:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| DOPG:Chol:PEG2000 (65:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (0.5:69.5:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (10:60:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (1:69:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (20:50:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (2.5:67.5:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol 30:40:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (40:30:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (50:20:30)ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (5:65:30 )-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (60:10:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (10:55:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (1:64:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (20:45:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (2.5:62.5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (30:35:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (40:25:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (50:15:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (5:60:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (60:5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG sodium | DOPG sodium is a naturally occurring anionic phospholipid, containing oleic acid (18:1) inserted at the sn-1 and sn-2 positions. DOPG can form a lipid bilayer in an aqueous solution and is used in the generation of micelles, liposomes, and other artificial membranes. DOPG also exhibits anti-inflammatory properties [1]. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 67254-28-8. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-141571. | |
| D-O-Phospho threonine | D-O-Phospho threonine. Group: Biochemicals. Alternative Names: D-Threonine dihydrogen phosphate(ester); D-O-Phosphothreonine. Grades: Highly Purified. CAS No. 96193-69-0. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C4H10NO6P. US Biological Life Sciences. | Worldwide |
| Dopropidil | Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properties. Synonyms: 1-[1-(2-methylpropoxy)-3-(1-prop-1-ynylcyclohexyl)oxypropan-2-yl]pyrrolidine; 1-(1-((2-methylpropoxy)methyl)-2-((1-(1-propynyl)cyclohexyl)oxy)ethyl)pyrrolidine; 4205CERM; 4205CERM hydrochloride; CERM 4205; CERM4205; CERM-4205. CAS No. 79700-61-1. Molecular formula: C20H35NO2. Mole weight: 321.5. | |
| DOPS | DOPS (1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium salt) is high purity phospholipid utilized for liposome production. Synonyms: (2S,8R,19Z)-2-amino-5-hydroxy-11-oxo-8-[[(9Z)-1-oxo-9-octadecenyl]oxy]-4,6,10-trioxa-5-phosphaoctacos-19-enoic acid, 5-oxide, monosodium salt; L-α-Phosphatidyl-L-serine, dioleoyl sodium salt; 1,2-Dioleoyl-sn-Glycero-3-Phosphatidylserine Na salt; 18:1 PS. Grade: >98%. CAS No. 90693-88-2. Molecular formula: C42H77NO10P; Na. Mole weight: 810.03. | |
| DORA-22 | DORA-22 is a dual orexin receptor antagonist. It can improve mild stress-induced insomnia with minimal effect on memory. Synonyms: DORA22; DORA 22; (5-Fluoro-2-(pyrimidin-2-yl)phenyl)((2R,5R)-5-(((5-fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)methanone. CAS No. 1088991-95-0. Molecular formula: C23H22F2N4O2. Mole weight: 424.44. | |
| Doramapimod | Doramapimod (BIRB 796) is a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB-796 has entered clinical trials for the treatment of autoimmune diseases. Synonyms: Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-; N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea; Birb 796; BIRB 796BS; BRB 796; UNC 10225354; UNC10225354; 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea. Grade: >98%. CAS No. 285983-48-4. Molecular formula: C31H37N5O3. Mole weight: 527.66. | |
| Doramapimod | Doramapimod is a highly potent inhibitor of p38 mitogen-activated protein kinase (MAPK). Doramapimod is a potential agent for the treatment of inflammatory diseases. Doramapimod blocks baseline and bortezomib-triggered upregulation of p38 MAPK and Hsp27 phosphorylation leading to enhanced cytotoxicity and caspase activation. Group: Biochemicals. Alternative Names: N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea; BIRB 796BS; Birb 796. Grades: Highly Purified. CAS No. 285983-48-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Doramapimod | Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38?=38 nM, for p38?=65 nM, for p38?=200 nM, and for p38?=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BIRB 796. CAS No. 285983-48-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10320. | |
| Doramapimod (1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea, BRRB 796) | Cell-permeable. A potent protein kinase inhibitor with a >330-fold selectivity for p38 MAPK compared with 12 other protein kinases. In contrast to other p38 MAPK inhibitors, doramapimod prevents both the kinetic activity and phosphorylation of p38 MAPK by binding to the ATP pocket as well as to a novel allosteric binding site on p38 MAPK. Group: Biochemicals. Grades: Highly Purified. CAS No. 285983-48-4. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Doramectin | Doramectin is a derivative of ivermectin, which is an anthelmintic. Doramectin is an antiparasitic antibiotic produced by Streptomyces. Synonyms: UK67994. Grade: 95%. CAS No. 117704-25-3. Molecular formula: C50H74O14. Mole weight: 899.11. | |
| Doramectin | analytical standard. Group: Pesticides & metabolites standardspesticides & metabolitespharma & vet compounds & metabolitesstable isotope labelled compoundsstandards for environmental regulatory methodspharma & vet compounds & metabolitesapi standardspharmaceutical toxicology. Alternative Names: 25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-avermectin A1a, 25-Cyclohexylavermectin B1, 25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin a1a, L 701023, Dectomax, Doramectin, Doramectin A1a, Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], avermectin A1a deriv., UK 67994. |  |
| Doramectin | Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model [1] [2] [3]. Uses: Scientific research. Group: Natural products. CAS No. 117704-25-3. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-17035. | |
| Doramectin | Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 25-CYCLOHEXYL-5-O-DEMETHYL-25-DE(1-METHYLPROPYL)AVERMECTIN;DORAMECTIN;Doramectin VETRANAL;Doromectin;_x00B_25-Cclohexyl-avermectin B1;25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin A1A;Dectoma;UK-67994. Product Category: Inhibitors. Appearance: Solid. CAS No. 117704-25-3. Molecular formula: C50H74O14. Mole weight: 899.11. Purity: 0.9896. Canonical SMILES: CO[C@@H]1[C@@H](O[C@]2([H])O[C@@H](C)[C@H](O)[C@@H](OC)C2)[C@H](C)O[C@@]([H])(O[C@H](/C(C)=C/C[C@]3([H])C[C@]([H])(OC4=O)C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O3)[C@@H](C)/C=C/C=C7CO[C@@]8([H])[C@]\7(O)[C@@]4([H])C=C(C)[C@H]8O)C1. Product ID: ACM117704253. Alfa Chemistry ISO 9001:2015 Certified. | |
| Doramectin | Doramectin is a biosynthetic avermectin derived from a mutant of the original Streptomyces avermitilis strain supplemented with a cyclohexylcaboxylic acid starting unit. Doramectin was developed as an anthelmintic for internal parasite control. The presence of the cyclohexyl group replacing the sec-butyl moiety affords greater hydrophobicity and longer biological half-life compared to avermectin. Like the other milbemycin / avermectins, it selectively binds to parasite glutamate-gated chloride ion channels and disrupts neurotransmission leading to paralysis and death of the parasite. Group: Biochemicals. Grades: Highly Purified. CAS No. 117704-25-3. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Doramectin | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C50H74O14. CAS No. 117704-25-3. Prepack ID 48672805-1g. Molecular Weight 899.11. See USA prepack pricing. |  |
| Doramectin (25-Cyclohexyl-5-O-demethyl-25-de (1-methylpropyl) avermectin A1A,. 25-Cylohexyl-avermectin B1, UK-67994, Dectomax) | Doramectin is a biosynthetic avermectin derived from a mutant of the original Streptomyces avermitilis strain supplemented with a cyclohexylcaboxylic acid starting unit. Doramectin was developed as an anthelmintic for internal parasite control. The presence of the cyclohexyl group replacing the sec-butyl moiety affords greater hydrophobicity and longer biological half-life compared to avermectin. Like the other milbemycin / avermectins, it selectively binds to parasite glutamate-gated chloride ion channels and disrupts neurotransmission leading to paralysis and death of the parasite. Group: Biochemicals. Alternative Names: 25-Cyclohexyl-5-O-demethyl-25-de (1-methylpropyl) avermectin A1A; 25-Cylohexyl-avermectin B1; UK-67994; Dectomax. Grades: Highly Purified. CAS No. 117704-25-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Doramectin aglycone | It is an acid degradation product produced by hydrolysis of the disaccharide unit of doramectin. It is an inhibitor of nematode larval development and an anthelmintic in animal health. It has no paralytic activity. Synonyms: 25R-cyclohexyl-22,23-didehydro-5-O-demethyl-28-deoxy-6R,28-epoxy-13S-hydroxy-milbemycin B. Grade: >95% by HPLC. CAS No. 1987883-26-0. Molecular formula: C36H50O8. Mole weight: 610.78. | |
| Doramectin Impurity 1 | An impurity of Doramectin, a large macrocyclic lactone fermentation product of Streptomyces avermitilis. Doramectin has been used as a veterinary medication for the treatment of parasites. Synonyms: 23-hydroxy Doramectin. Grade: ≥95%. Molecular formula: C50H76O15. Mole weight: 917.13. | |
| Doramectin Impurity 4 | An impurity of Doramectin, a large macrocyclic lactone fermentation product of Streptomyces avermitilis. Doramectin has been used as a veterinary medication for the treatment of parasites. Grade: ≥95%. Molecular formula: C50H76O14. Mole weight: 901.13. | |
| Doramectin Impurity 5 | An impurity of Doramectin, a large macrocyclic lactone fermentation product of Streptomyces avermitilis. Doramectin has been used as a veterinary medication for the treatment of parasites. Synonyms: 14-demethyl Doramectin. Grade: ≥95%. CAS No. 2560603-30-5. Molecular formula: C49H72O14. Mole weight: 885.08. | |
| Doramectin Impurity 6 | An impurity of Doramectin, a large macrocyclic lactone fermentation product of Streptomyces avermitilis. Doramectin has been used as a veterinary medication for the treatment of parasites. Synonyms: Doramectin, epi-. Grade: ≥95%. Molecular formula: C50H74O14. Mole weight: 899.11. | |
| Doramectin Impurity 7 | An impurity of Doramectin, a large macrocyclic lactone fermentation product of Streptomyces avermitilis. Doramectin has been used as a veterinary medication for the treatment of parasites. Synonyms: 5-methoxy Doramectin. Grade: ≥95%. Molecular formula: C51H76O14. Mole weight: 913.14. | |
| Doramectin monosaccharide | It is an acid degradation product produced by selective hydrolysis of the terminal saccharide unit of doramectin. It is a potent inhibitor of nematode larval development and an anthelmintic in animal health. Synonyms: 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-O-demethyl-25-de(1-methylpropyl)-avermectin A1a. Grade: >95% by HPLC. CAS No. 165108-44-1. Molecular formula: C43H62O11. Mole weight: 754.95. | |
| Doramectin (Standard) | Doramectin (Standard) is the analytical standard of Doramectin. This product is intended for research and analytical applications. Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model [1] [2] [3]. Uses: Scientific research. Group: Natural products. CAS No. 117704-25-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-17035R. | |
| Dorastine | Dorastine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Dorastine;8-Chloro-2,3,4,5-tetrahydro-2-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-1H-pyrido[4,3-b]indole;8-Chloro-2,3,4,5-tetrahydro-2-methyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole. Product Category: Heterocyclic Organic Compound. CAS No. 21228-13-7. Molecular formula: C20H22ClN3. Mole weight: 339.86. Density: 1.23g/cm³. Product ID: ACM21228137. Alfa Chemistry ISO 9001:2015 Certified. | |
| Doravirine | Doravirine (MK-1439) is a highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor with IC 50 s of 4.5 nM, 5.5 nM and 6.1 nM against the wild type and K103N and Y181C reverse transcriptase mutants, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK-1439. CAS No. 1338225-97-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16767. | |
| Doravirine | Doravirine is a non-nucleoside reverse transcriptase inhibitor under development of Merck & Co. IC 50 value is 12 nM against the wild type, 21nM against K103N, 31 nM against Y181C, 33nM against K103N/Y181C mutant viruses in vitro. MK-1439 exhibited similar antiviral activities against 10 different HIV-1 subtype viruses. Phase III for the treatment of HIV-1 infections is on-going. Uses: Hiv-1 infections. Synonyms: MK-1439; MK 1439; MK1439; MK-1439-019; 3-Chloro-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile. Grade: 98%. CAS No. 1338225-97-0. Molecular formula: C17H11ClF3N5O3. Mole weight: 425.75. | |
| Doravirine-[13C6] | Labelled Doravirine. Doravirine is a non-nucleoside reverse transcriptase inhibitor under development of Merck & Co. IC 50 value is 12 nM against the wild type, 21nM against K103N, 31 nM against Y181C, 33nM against K103N/Y181C mutant viruses in vitro. MK-1439 exhibited similar antiviral activities against 10 different HIV-1 subtype viruses. Phase III for the treatment of HIV-1 infections is on-going. Synonyms: 3-Chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile-13C6. Grade: 98%; 99% atom 13C. Molecular formula: C11[13C]6H11ClF3N5O3. Mole weight: 431.71. | |
| Doremox® | Doremox®. CAS No. 94201-73-7. VIGON Item # 502910. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers, Rose Pyran. |  America & Internationally |
| Doripenem | Doripenem (S 4661), a 1β-methyl parenteral carbapenem, has very broad-spectrum activity against Gram-positive and Gram-negative aerobic bacteria [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S 4661. CAS No. 148016-81-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-B0187. | |
| Doripenem | Antibacterial agent. Group: Biochemicals. Alternative Names: (4R, 5S, 6S) -3-[[ (3S, 5S) -5-[[ (Aminosulfonyl) amino]methyl]-3-pyrrolidinyl]thio]-6-[ (1R) -1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylic Acid;S 4661. Grades: Highly Purified. CAS No. 148016-81-3. Pack Sizes: 10mg, 25mg, 50mg. Molecular Formula: C15H24N4O6S2. US Biological Life Sciences. | Worldwide |
| Doripenem | 100mg Pack Size. Group: Antibiotics, Biochemicals, Research Organics & Inorganics. Formula: C15H24N4O6S2. CAS No. 148016-81-3. Prepack ID 14558613-100mg. Molecular Weight 420.51. See USA prepack pricing. | |
| Doripenem | Doripenem is a broad spectrum antibiotic that is in the β-lactam subclass known as carbapenems. It inhibits the synthesis of bacterial cell walls by attaching to penicillin-binding proteins. It is effective against many Gram-negative and Gram-positive bacteria and is more effective against P. aeruginosa than other carbapenems. However, it is not effective against multidrug-resistant S. aureus. Synonyms: Doribax; Finibax; S 4661; S4661; S-4661. Grade: >98%. CAS No. 148016-81-3. Molecular formula: C15H24N4O6S2. Mole weight: 420.5. | |
| Doripenem-d4 sodium salt | Doripenem-d4 is used as an internal standard for the quantification of doripenem by GC- or LC-MS. Doripenem is a broad-spectrum antibiotic in the β-lactam subclass known as carbapenems. It is active against Gram-negative and Gram-positive bacteria, including S. aureus, S. pneumoniae, E. coli, and K. pneumoniae. It inhibits bacterial cell wall synthesis via forming stable acyl enzymes with penicillin-binding proteins, thereby inactivating them. Synonyms: 3-[[(3S,5S)-5S-[[(aminosulfonyl)amino]methyl]-3-pyrrolidinyl]thio]-6S-[(1R)-1-hydroxyethyl]-4R-(methyl-d3)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-4-d1-2-carboxylic acid, monosodium salt. Grade: ≥99% atom D. Molecular formula: C15H19D4N4O6S2·Na. Mole weight: 446.51. | |
| Doripenem Dimer | Doripenem Dimer. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C30H48N8O12S4. US Biological Life Sciences. | Worldwide |
| Doripenem hydrate | Doripenem Hydrate is an ultra-broad-spectrum injectable antibiotic, used to treat complicated intra-abdominal infections and complicated urinary tract infections. Synonyms: S-4661; S 4661; S4661. Grade: >98%. CAS No. 364622-82-2. Molecular formula: C15H24N4O6S2.H2O. Mole weight: 438.52. | |
| Doripenem hydrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Doripenem hydrate | Doripenem hydrate. Group: Biochemicals. Grades: Highly Purified. CAS No. 364622-82-2. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
